Cargando…

Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study

BACKGROUND: The number of primary care referrals of women with breast symptoms to symptomatic breast units (SBUs) has increased exponentially in the past decade in Ireland. The aim of this study is to develop and validate a clinical prediction rule (CPR) to identify women with breast cancer so that...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvin, Rose, Joyce, Doireann, Downey, Eithne, Boland, Fiona, Fahey, Tom, Hill, Arnold K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197234/
https://www.ncbi.nlm.nih.gov/pubmed/25277332
http://dx.doi.org/10.1186/1471-2407-14-743
_version_ 1782339583340445696
author Galvin, Rose
Joyce, Doireann
Downey, Eithne
Boland, Fiona
Fahey, Tom
Hill, Arnold K
author_facet Galvin, Rose
Joyce, Doireann
Downey, Eithne
Boland, Fiona
Fahey, Tom
Hill, Arnold K
author_sort Galvin, Rose
collection PubMed
description BACKGROUND: The number of primary care referrals of women with breast symptoms to symptomatic breast units (SBUs) has increased exponentially in the past decade in Ireland. The aim of this study is to develop and validate a clinical prediction rule (CPR) to identify women with breast cancer so that a more evidence based approach to referral from primary care to these SBUs can be developed. METHODS: We analysed routine data from a prospective cohort of consecutive women reviewed at a SBU with breast symptoms. The dataset was split into a derivation and validation cohort. Regression analysis was used to derive a CPR from the patient’s history and clinical findings. Validation of the CPR consisted of estimating the number of breast cancers predicted to occur compared with the actual number of observed breast cancers across deciles of risk. RESULTS: A total of 6,590 patients were included in the derivation study and 4.9% were diagnosed with breast cancer. Independent clinical predictors for breast cancer were: increasing age by year (adjusted odds ratio 1.08, 95% CI 1.07-1.09); presence of a lump (5.63, 95% CI 4.2-7.56); nipple change (2.77, 95% CI 1.68-4.58) and nipple discharge (2.09, 95% CI 1.1-3.97). Validation of the rule (n = 911) demonstrated that the probability of breast cancer was higher with an increasing number of these independent variables. The Hosmer-Lemeshow goodness of fit showed no overall significant difference between the expected and the observed numbers of breast cancer (χ(2)(HL): 6.74, p-value: 0.56). CONCLUSIONS: This study derived and validated a CPR for breast cancer in women attending an Irish national SBU. We found that increasing age, presence of a lump, nipple discharge and nipple change are all associated with increased risk of breast cancer. Further validation of the rule is necessary as well as an assessment of its impact on referral practice.
format Online
Article
Text
id pubmed-4197234
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41972342014-10-16 Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study Galvin, Rose Joyce, Doireann Downey, Eithne Boland, Fiona Fahey, Tom Hill, Arnold K BMC Cancer Research Article BACKGROUND: The number of primary care referrals of women with breast symptoms to symptomatic breast units (SBUs) has increased exponentially in the past decade in Ireland. The aim of this study is to develop and validate a clinical prediction rule (CPR) to identify women with breast cancer so that a more evidence based approach to referral from primary care to these SBUs can be developed. METHODS: We analysed routine data from a prospective cohort of consecutive women reviewed at a SBU with breast symptoms. The dataset was split into a derivation and validation cohort. Regression analysis was used to derive a CPR from the patient’s history and clinical findings. Validation of the CPR consisted of estimating the number of breast cancers predicted to occur compared with the actual number of observed breast cancers across deciles of risk. RESULTS: A total of 6,590 patients were included in the derivation study and 4.9% were diagnosed with breast cancer. Independent clinical predictors for breast cancer were: increasing age by year (adjusted odds ratio 1.08, 95% CI 1.07-1.09); presence of a lump (5.63, 95% CI 4.2-7.56); nipple change (2.77, 95% CI 1.68-4.58) and nipple discharge (2.09, 95% CI 1.1-3.97). Validation of the rule (n = 911) demonstrated that the probability of breast cancer was higher with an increasing number of these independent variables. The Hosmer-Lemeshow goodness of fit showed no overall significant difference between the expected and the observed numbers of breast cancer (χ(2)(HL): 6.74, p-value: 0.56). CONCLUSIONS: This study derived and validated a CPR for breast cancer in women attending an Irish national SBU. We found that increasing age, presence of a lump, nipple discharge and nipple change are all associated with increased risk of breast cancer. Further validation of the rule is necessary as well as an assessment of its impact on referral practice. BioMed Central 2014-10-03 /pmc/articles/PMC4197234/ /pubmed/25277332 http://dx.doi.org/10.1186/1471-2407-14-743 Text en © Galvin et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Galvin, Rose
Joyce, Doireann
Downey, Eithne
Boland, Fiona
Fahey, Tom
Hill, Arnold K
Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study
title Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study
title_full Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study
title_fullStr Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study
title_full_unstemmed Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study
title_short Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study
title_sort development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197234/
https://www.ncbi.nlm.nih.gov/pubmed/25277332
http://dx.doi.org/10.1186/1471-2407-14-743
work_keys_str_mv AT galvinrose developmentandvalidationofaclinicalpredictionruletoidentifysuspectedbreastcanceraprospectivecohortstudy
AT joycedoireann developmentandvalidationofaclinicalpredictionruletoidentifysuspectedbreastcanceraprospectivecohortstudy
AT downeyeithne developmentandvalidationofaclinicalpredictionruletoidentifysuspectedbreastcanceraprospectivecohortstudy
AT bolandfiona developmentandvalidationofaclinicalpredictionruletoidentifysuspectedbreastcanceraprospectivecohortstudy
AT faheytom developmentandvalidationofaclinicalpredictionruletoidentifysuspectedbreastcanceraprospectivecohortstudy
AT hillarnoldk developmentandvalidationofaclinicalpredictionruletoidentifysuspectedbreastcanceraprospectivecohortstudy